China: GlaxoSmithKline plc Is Bribing Officials

HFA Padded
Mani
Published on
Updated on

GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives have confessed to charges of bribery and tax law violations, according to China’s security ministry. GlaxoSmithKline Executives Suspected Of Offering Bribes GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives are suspected of offering bribes to officials and doctors to enhance their product sales in China. According to Chinese security ministry, GSK offered bribes to Chinese government officials, medical associations, hospitals and doctors to enhance sales and prices of their products. Under China’s legal system, the GlaxoSmithKline plc (ADR) (NYSE:GSK) (LON:GSK) executives will be formally charged after the completion of the preliminary investigations. The statement from China’s Public Security Bureau…

This content is exclusively for paying members of Hedge Fund Alpha

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!
This article is only available for Premium Members
Subscribe today and get :
Insider Strategies and Letters to Shareholders from the Top Hedge Funds
Exclusive Access to coverage of Private, Closed-Door Investor Conferences
Hedge Fund Manager Research Currently Producing 21% – 40% Returns Annually

Don’t have an account?

Subscribe now and get 7 days free!
HFA Padded

Mani is a Senior Financial Consultant. He has worked in Senior Management role in large banking, financial and information technology organizations. He has provided solutions for major banking and securities firms across the globe in the area of retail, corporate and investment banking. He holds MBA (Finance) and Professional Management Accounting Qualifications. His hobbies are tracking global financial developments and watching sports